Gene Expression Analysis Market worth $4.3 Billion by 2018

Wednesday 5 March 2014, Amsterdam

The “Global Gene Expression Analysis Market (2013-2018)” analyzes and studies the major market drivers and restraints in North America, Europe, Asia, and the Rest of the World (RoW).

This report covers the definition, description, and forecast of the global gene expression analysis market in terms of instrumentation, consumables, services, and applications. Based on technology, the gene expression analysis instrumentation market comprises DNA microarrays, real-time PCR, next-generation sequencing, and others. The consumables market is categorized into DNA chips and reagents, while the services market is further sub-segmented into gene expression profiling services, bioinformatics solutions, data analysis software, and others.

Over the years, gene expression analysis has evolved significantly and is widely used for the diagnosis and treatment of various disorders like cancer, Alzheimer’s, and Parkinson’s, among others. In the past few years, the market has witnessed significant technological advancements, as companies have introduced newer sequencing and analysis platforms. This has aided in the diagnosis and treatment of diseases. Increasing number of cancer patients, growth in the number of funding activities, technological advancements, and increased interest in gene expression for research and discovery are the major factors driving the growth of this market. Moreover, various government bodies have extended their help in the form of investments, funds, and grants, which has further stimulated the growth of the gene expression analysis market.

North America dominated the global gene expression analysis market, followed by Europe and Asia. The continued developments in the North American market are triggered by the increase in funding, to address the growth in the number of cancer patients. Asia is expected to grow at the highest CAGR. This can be attributed to the presence of high-growth markets such as India and China, improved funding scenario in this region, increasing number of conferences and exhibitions on gene expression, and increased focus on cancer research.

Life Technologies (U.S.), QIAGEN N.V. (Netherlands), Illumina, Inc. (U.S.), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies (U.S.), Affymetrix, Inc. (U.S.), GE Healthcare (U.K.), Thermo Fisher Scientific (U.S.), PerkinElmer, Inc. (U.S.), Luminex Corporation (U.S.), and Oxford Gene Technology, Inc. (U.K.) are some of the prominent players in the global gene expression analysis market.